Medtronic's China unit fined 118.5m yuan for price fixing
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Beijing
A CHINESE regulator has fined a local unit of US-listed medical device firm Medtronic PLC 118.5 million yuan (S$24.4 million) for price fixing, the National Development and Reform Commission (NDRC) said in a statement on Wednesday.
The state planner said it had fined Medtronic (Shanghai) Management Co following an investigation into monopolistic behaviour related to the firm's cardiovascular and diabetes medical device products.
Share with us your feedback on BT's products and services
TRENDING NOW
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Vietnam formalises new state leadership, redefining ‘four pillars’ power balance